204 related articles for article (PubMed ID: 23821301)
1. Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility.
Zhou ZC; Wang J; Cai ZH; Zhang QH; Cai ZX; Wu JH
Tumour Biol; 2013 Dec; 34(6):3437-41. PubMed ID: 23821301
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.
Iqbal Mu; Khan TA; Maqbool SA
PLoS One; 2015; 10(3):e0122657. PubMed ID: 25799416
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway.
Amadori D; Serra P; Masalu N; Pangan A; Scarpi E; Bugingo AM; Katabalo D; Ibrahim T; Bongiovanni A; Miserocchi G; Spadazzi C; Liverani C; Turri V; Tedaldi R; Mercatali L
Oncotarget; 2017 Feb; 8(8):13142-13156. PubMed ID: 28061456
[TBL] [Abstract][Full Text] [Related]
4. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.
Fang Y; van Meurs JB; Bergink AP; Hofman A; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2003 Sep; 18(9):1632-41. PubMed ID: 12968672
[TBL] [Abstract][Full Text] [Related]
5. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
6. Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.
Wang K; Wu G; Li J; Song W
BMC Cancer; 2016 Aug; 16(1):674. PubMed ID: 27553621
[TBL] [Abstract][Full Text] [Related]
7. Associations between vitamin D receptor polymorphisms and breast cancer risk.
Wang J; He Q; Shao YG; Ji M; Bao W
Tumour Biol; 2013 Dec; 34(6):3823-30. PubMed ID: 23900677
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.
Luo S; Guo L; Li Y; Wang S
Tumour Biol; 2014 Jan; 35(1):785-90. PubMed ID: 24048755
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the relation between vitamin D receptor gene BsmI polymorphism and susceptibility to ovarian cancer.
Zhang Y; Tong SC; Guan LH; Na F; Zhao W; Wei L
Tumour Biol; 2013 Dec; 34(6):3317-21. PubMed ID: 23784456
[TBL] [Abstract][Full Text] [Related]
10. The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.
Huang J; Huang J; Ma Y; Wang H; Yang J; Xiong T; Du L
Mol Biol Rep; 2013 Jul; 40(7):4219-25. PubMed ID: 23649760
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.
Serrano D; Gnagnarella P; Raimondi S; Gandini S
Eur J Cancer Prev; 2016 Jan; 25(1):85-96. PubMed ID: 25738688
[TBL] [Abstract][Full Text] [Related]
12. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.
Li K; Li W; Zou H; Zhao L
Tumour Biol; 2014 Jan; 35(1):351-6. PubMed ID: 23979975
[TBL] [Abstract][Full Text] [Related]
13. The VDR gene FokI polymorphism and ovarian cancer risk.
Xu H; Li S; Qiu JQ; Gao XL; Zhang P; Yang YX
Tumour Biol; 2013 Dec; 34(6):3309-16. PubMed ID: 24078452
[TBL] [Abstract][Full Text] [Related]
14. Association between vitamin D receptor BsmI, FokI, and Cdx2 polymorphisms and osteoporosis risk: an updated meta-analysis.
Chen B; Zhu WF; Mu YY; Liu B; Li HZ; He XF
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627819
[TBL] [Abstract][Full Text] [Related]
15. Association between vitamin D receptor poly(A) polymorphism and breast cancer risk: a meta-analysis.
Xu J; Li H; Gu L; Zhou X
Tumour Biol; 2014 Jan; 35(1):589-93. PubMed ID: 24037913
[TBL] [Abstract][Full Text] [Related]
16. CDX2 VDR polymorphism and colorectal cancer.
Slattery ML; Herrick J; Wolff RK; Caan BJ; Potter JD; Sweeney C
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2752-5. PubMed ID: 18086783
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer.
Raza S; Dhasmana A; Bhatt MLB; Lohani M; Arif JM
Asian Pac J Cancer Prev; 2019 Jan; 20(1):199-206. PubMed ID: 30678432
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.
Pei J; Li F; Wang B
Tumour Biol; 2013 Dec; 34(6):4073-9. PubMed ID: 23888322
[TBL] [Abstract][Full Text] [Related]
19. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.
Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q
Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475
[TBL] [Abstract][Full Text] [Related]
20. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.
Torkko KC; van Bokhoven A; Mai P; Beuten J; Balic I; Byers TE; Hokanson JE; Norris JM; Barón AE; Lucia MS; Thompson IM; Leach RJ
Clin Cancer Res; 2008 May; 14(10):3223-9. PubMed ID: 18483391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
